Hoth Therapeutics Inc (HOTH)
1.22
+0.06
(+5.17%)
USD |
NASDAQ |
May 24, 16:00
1.19
-0.03
(-2.46%)
After-Hours: 20:00
Hoth Therapeutics Enterprise Value: -1.598M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | -1.598M |
| May 23, 2024 | -1.892M |
| May 22, 2024 | -1.696M |
| May 21, 2024 | -1.770M |
| May 20, 2024 | -1.697M |
| May 17, 2024 | -1.794M |
| May 16, 2024 | -1.745M |
| May 15, 2024 | -1.892M |
| May 14, 2024 | -1.794M |
| May 13, 2024 | -1.598M |
| May 10, 2024 | -1.842M |
| May 09, 2024 | -1.696M |
| May 08, 2024 | -1.647M |
| May 07, 2024 | -1.745M |
| May 06, 2024 | -1.843M |
| May 03, 2024 | -1.647M |
| May 02, 2024 | -1.554M |
| May 01, 2024 | -1.745M |
| April 30, 2024 | -1.623M |
| April 29, 2024 | -1.696M |
| April 26, 2024 | -1.892M |
| April 25, 2024 | -1.843M |
| April 24, 2024 | -1.843M |
| April 23, 2024 | -1.745M |
| April 22, 2024 | -1.940M |
| Date | Value |
|---|---|
| April 19, 2024 | -1.718M |
| April 18, 2024 | -1.794M |
| April 17, 2024 | -1.549M |
| April 16, 2024 | -1.696M |
| April 15, 2024 | -1.696M |
| April 12, 2024 | -1.598M |
| April 11, 2024 | -1.354M |
| April 10, 2024 | -1.403M |
| April 09, 2024 | -1.305M |
| April 08, 2024 | -1.012M |
| April 05, 2024 | -0.7183M |
| April 04, 2024 | -0.5716M |
| April 03, 2024 | -0.6205M |
| April 02, 2024 | -0.865M |
| April 01, 2024 | -0.6205M |
| March 28, 2024 | -2.599M |
| March 27, 2024 | -3.215M |
| March 26, 2024 | -2.731M |
| March 25, 2024 | -2.683M |
| March 22, 2024 | -2.770M |
| March 21, 2024 | -2.118M |
| March 20, 2024 | -2.944M |
| March 19, 2024 | -3.422M |
| March 18, 2024 | -4.292M |
| March 15, 2024 | -4.249M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.117M
Minimum
May 17 2023
72.61M
Maximum
Jun 11 2019
14.87M
Average
10.94M
Median
Oct 25 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 755.01M |
| Electromed Inc | 132.41M |
| Xtant Medical Holdings Inc | 120.35M |
| Asensus Surgical Inc | 57.64M |
| Myomo Inc | 99.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.041M |
| Total Expenses (Quarterly) | 2.054M |
| EPS Diluted (Quarterly) | -0.46 |
| Earnings Yield | -159.0% |